Corporate
Pharma
Services
Presentations
 
Letter for shareholders
BIO-CEO Investor conference
New York City, 15 February  2011
   Film Corporate

presentation_hybrigenics

     

 

 

 (french version Only)

      SFAF_hybrigenics               

   film_hybrigenics         

(french version only)
 



Hybrigenics maintains stable EUR 2 million revenues in first half of 2011

 

Hybrigenics and Servier enter into a licence and research collaboration agreement in oncology and other therapeutic fields  

Hybrigenics unveils final results of inecalcitol Phase IIa clinical study  
© 2012 hybrigenics